Ken Cornell

    Calculated based on number of publications stored in Pure and citations from Scopus
    1990 …2024

    Research activity per year

    Personal profile

    About

    After earning a Ph.D. in Biochemistry and Molecular Biology from Oregon Health Sciences University, and serving as a Postdoctoral Fellow in Molecular Immunology at the Portland (OR) VA Medical Center, Dr. Ken Cornell joined the faculty of the Department of Chemistry and Biochemistry at Boise State University in 2004. Dr. Cornell's research interests include antibiotic development targeting bacterial and parasite methionine salvage, farnesol metabolism in eukaryotic cells, and development of forensic reagents. One of the primary investigations in his lab is the identification of new targets for antimicrobial drug development.
    Some of Dr. Cornell's current ongoing research support includes “A West Nile Virus Vaccine” Agency: DOD/CDMRP, Date: 09/09-08/10($940,000), “Global Consequences of Interruption of Microbial Autoinducer Signaling” Agency: NIH / Idaho INBRE, Date: 5/09-4/14 ($352,000), and “Acquisition of a Liquid Chromatography Tandem Mass Spectrometer” Agency: NSF MRI, Date: 08/09–07/12 ($597,877).

    Expertise related to UN Sustainable Development Goals

    In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

    • SDG 3 - Good Health and Well-being

    Fingerprint

    Dive into the research topics where Ken Cornell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
    • 1 Similar Profiles

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or